Eli Lilly and CompanyLLYNYSE
Loading

Analyst Sentiment

Analysts lean bullish — 85% recommend buying.

Consensus Rating
Buy
26 analysts·High coverage
85%
Rating Distribution
Strong Buy
00%
Buy
2285%
Hold
415%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 19% higher.

Bear Case
$830.00
-18%
Consensus
$1214.28
+19%
Bull Case
$1350.00
+33%
Price Range26 analysts
Low
Consensus
High
$830.00
$1350.00
Current Target
Current Price
$1017.97
Upside to Target
$196.31

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$34.27(16 analysts)
P/E44x
Current: 44.3x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+15.88%
EPS+21.66%
FY2028
Rev+13.05%
EPS+18.48%
FY2029
Rev+9.73%
EPS+12.15%

Earnings Surprises

Beat rate:83%(10/12 quarters)
Avg surprise:+27.2%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions